Limited Offer
Migraine Management
- 1st Edition, Volume 199 - February 1, 2024
- Editors: Jerry W. Swanson, Manjit Matharu
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 8 2 3 3 5 7 - 3
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 2 3 4 8 1 - 5
Migraine Management, Volume 199 covers the effective treatment of migraines, including different subtypes of migraines in different patient populations. The classific… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteMigraine Management, Volume 199 covers the effective treatment of migraines, including different subtypes of migraines in different patient populations. The classification and diagnostic criteria of common and uncommon subtypes of migraine is explored in detail, including childhood variants. An in-depth analysis of the pharmacology of acute and prophylactic agents is presented, along with an evidence-based review of pharmacologic management. This includes recently developed CGRP monoclonal antibodies and non-peptide small molecule CGRP antagonists. Advances in neuromodulatory treatments, both noninvasive and implantable are also critically reviewed.
Finally, specific treatment-related issues in pregnancy and lactation and childhood as well as the elderly are covered. Issues related to the diagnosis and management of vestibular migraine and the co-morbid disorder of persistent postural-perceptual dizziness are also explored.
- Summarizes evidence-based best treatment for migraines
- Differentiates treatment based on patient population, migraine type, and clinical setting
- Includes pharmacological, biobehavioral, and physical treatments
- Provides specialized treatments for children, the elderly, and pregnant patients
- Cover image
- Title page
- Table of Contents
- Series Page
- Copyright
- Handbook of Clinical Neurology 3rd Series
- Foreword
- Preface
- Contributors
- Section I: Migraine management
- Chapter 1 Nonspecific analgesics, combination analgesics, and antiemetics
- Abstract
- Introduction
- How to Evaluate the Outcomes?
- Strategies
- References
- Chapter 2 The 5-HT1B and 5-HT1D agonists in acute migraine therapy: Ergotamine, dihydroergotamine, and the triptans
- Abstract
- Introduction
- Ergotamine
- Dihydroergotamine
- Triptans
- References
- Chapter 3 5-HT1F agonists
- Abstract
- Introduction
- History and Development
- Pharmacology
- Efficacy
- Tolerability/Safety
- Clinical Approach
- Conclusion
- References
- Chapter 4 CGRP receptor antagonists (gepants)
- Abstract
- Introduction
- Gepants as a New Class of Migraine Medications
- Evidence for Efficacy of Acute Treatment
- Safety and Tolerability
- Pharmacology
- Gepants in Migraine Prevention
- Limitations
- Future Perspectives and Conclusions
- References
- Chapter 5 Preventive treatment of migraine: Non-specific oral agents
- Abstract
- Introduction
- Antidepressants
- Antihypertensives
- Anticonvulsants
- Other anticonvulsants
- Other anticonvulsants with insufficient evidence for use in migraine prevention
- Miscellaneous Migraine Preventives
- Conclusions
- References
- Chapter 6 OnabotulinumtoxinA: Discussion of the evidence for effectiveness of OnabotulinumA and its place in chronic migraine treatment
- Abstract
- Introduction
- Botulinum Neurotoxins
- Mechanism of Action of OnabotulinumtoxinA
- Injection technique
- Efficacy of OnabotulinumtoxinA in headache disorders
- PREEMPT 1 and 2. The study injection paradigm
- Real life studies
- Safety and tolerability of OnabotulinumtoxinA
- Place of OnabotulinumtoxinA in the prevention of chronic migraine
- Final considerations
- Conclusions
- References
- Chapter 7 CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention
- Abstract
- Introduction
- CGRP Mechanism
- Anti-CGRP Monoclonal Antibodies
- Gepants
- References
- Chapter 8 Nutraceuticals in migraine
- Abstract
- Nutraceuticals in Migraine
- Phytomedicines in Migraine
- Phytomedicines With Clinical Evidence in Migraine
- Cannabis sativa
- Summary
- Functional Foods and Diet Interventions in Migraine
- Polyunsaturated Fatty Acids (PUFAs) in Migraine
- Melatonin in Migraine
- Probiotics and Prebiotics in Migraine
- Traditional Medicine Approaches Worldwide in Migraine Treatment
- l-Carnitine Supplementation in Migraine
- Conclusions
- References
- Chapter 9 Interventional treatments
- Abstract
- Introduction
- Indications
- Clinical Outcomes and Evidence for Efficacy in Migraine
- Complications
- Discussion
- References
- Chapter 10 Biobehavioral treatments of migraine
- Abstract
- Introduction
- Behavioral and Psychosocial Factors in Migraine Headache
- The Self-Management Model and Its Application to Headache
- Overview of Behavioral Interventions for the Self-Management for Migraine
- Effectiveness of Behavioral Treatments for Migraine
- Alternate Treatment Formats for Behavioral Headache Interventions
- Emerging Nonpharmacologic Therapies for Migraine
- Underutilization of Behavioral Interventions for Migraine
- Conclusion
- References
- Chapter 11 Physical treatment of migraine
- Abstract
- Introduction
- Acupuncture
- Spinal Manipulation
- Massage
- Physical Therapy and Exercise
- Conclusion
- References
- Chapter 12 Neuromodulation in migraine
- Abstract
- Introduction
- Central Neuromodulation
- Peripheral Neuromodulation
- Conclusion
- References
- Section II: Guidelines
- Chapter 13 Evidence-based symptomatic treatment of migraine
- Abstract
- Introduction
- Treatment Strategy
- Patient Education
- Pharmacological Treatment
- Nonpharmacological Treatment
- Rescue Treatment and Symptomatic Treatment in the Emergency Department
- Unmet Needs and Emerging Treatments
- Conclusions
- References
- Chapter 14 Evidence-based preventive treatment of migraine☆
- Abstract
- Introduction
- Oral Migraine Preventatives
- OnabotulinumtoxinA
- CGRP Monoclonal Antibodies
- CGRP Antagonists
- Evidence-Based Preventive Treatment (a World Perspective)
- References
- Section III: Special cases/situations
- Chapter 15 Treatment in the emergency department
- Abstract
- Introduction
- Epidemiology and Role of ED in Migraine Treatment
- Treatments
- Conclusion
- References
- Chapter 16 Special considerations in migraine during pregnancy and lactation
- Abstract
- Introduction
- Effects of Migraine on Pregnancy
- References
- Chapter 17 Special considerations in management of migraine in the elderly
- Abstract
- Introduction
- Epidemiology of Migraine in the Elderly
- Diagnosis of Migraine in the Elderly
- Differential Diagnosis of Migraine in the Elderly
- Relevant Comorbidities of Migraine in the Elderly
- Interaction of Migraine With Cognitive Impairment in the Elderly
- Conclusion
- References
- Chapter 18 Management of medication overuse headache
- Abstract
- Introduction
- Classification
- Epidemiology
- Prevention
- Prescription of Prophylactic Treatment
- Effects of Treatments on MOH-Related Burden and PROs
- Predictors of Failure of Treatments
- Conclusions
- Future Research
- References
- Further reading
- Section IV: Outcome measures
- Chapter 19 Outcome measures for migraine: Measuring the impact of migraine and results of migraine treatment
- Abstract
- Introduction
- Selecting What to Measure
- Selecting How to Measure
- Considerations for Selecting PRO Measures
- Conclusions
- Acknowledgments
- References
- Section V: Diagnosis and treatment of other migraine subtypes
- Chapter 20 Menstrually associated migraine
- Abstract
- Introduction
- Definition and Diagnosis
- Epidemiology
- Pathophysiology
- Clinical Manifestations
- Treatment
- Future Directions
- Conclusions
- References
- Chapter 21 Hemiplegic migraine
- Abstract
- Introduction
- Clinical Characteristics
- Investigations
- Differential Diagnosis
- Pathophysiology
- Genetically Related Disorders
- Treatment
- Conclusion
- References
- Chapter 22 Migraine with brainstem aura
- Abstract
- Introduction
- Migraine With Brainstem Aura (2013–present): ICHD-3 beta, ICHD-3
- Basilar Artery Migraine (1961–87): Prior to availability of ICHD classification criteria
- Basilar-type Migraine (1988–2003): ICHD-1
- Basilar-type Migraine (2004–13): ICHD-2
- Summary and Practical Conclusions
- References
- Chapter 23 Retinal migraine
- Abstract
- Introduction
- Pathogenesis and Pathophysiology
- Epidemiology
- Differential Diagnosis
- Diagnostic Workup
- Prognosis and Complications
- Management
- References
- Chapter 24 Vestibular migraine and persistent postural perceptual dizziness
- Abstract
- Introduction
- Vestibular Migraine
- Persistent Postural Perceptual Dizziness
- Areas of Uncertainty Between Vestibular Migraine and PPPD
- Managing Coexisting VM and PPPD and Other Common Comorbidities
- Conclusion
- References
- Chapter 25 Status migrainosus
- Abstract
- Introduction
- Pathophysiology of Status Migrainosus
- Epidemiology and Clinical Presentation of Status Migrainosus
- The Burden of Status Migrainosus
- Secondary Mimics
- Treatment of Status Migrainosus
- References
- Chapter 26 Persistent aura, visual snow, and other visual symptoms
- Abstract
- Introduction
- Transient Visual Phenomena
- Migraine Aura, Migraine Aura Status, Prolonged Aura, Persistent Aura Without Infarction
- Visual Snow and Visual Snow Syndrome
- References
- Chapter 27 Migrainous infarction
- Abstract
- Introduction
- The Migraine–Stroke Association
- The ICHD-3 Definition of Migrainous Infarction
- Epidemiology
- Possible Pathophysiology
- Clinical and Radiological Presentation
- Risk Factors
- Evaluation and Treatment
- Conclusion
- Conflict of interest statement
- References
- Further reading
- Chapter 28 Migraine in children and adolescents: Assessment and diagnosis
- Abstract
- Introduction
- Clinical History for the Diagnosis of Childhood Migraine
- Assessment for Comorbidities
- Past History and Evolution of the Headache Disorder
- Summary
- References
- Chapter 29 Management of migraine in children and adolescents
- Abstract
- Introduction
- Management of Acute Migraine Episodes
- Preventive Treatment
- Other Medications
- Nutraceuticals
- Other Treatment Options
- The Future of Migraine Treatment in Child/Young People
- Summary
- References
- Section VI: Comorbidities of migraine
- Chapter 30 Psychiatric comorbidities of migraine
- Abstract
- Introduction
- Epidemiology
- Mechanisms
- Clinical Implications
- Referring Patients for Treatment of Psychiatric Disorders
- Conclusions
- References
- Chapter 31 Relationship of migraine and other forms of chronic pain
- Abstract
- Introduction
- Visceral Pain Conditions
- Nonvisceral Pain Conditions
- Treatment of Other Pain Conditions in Migraine
- Conclusion
- References
- Chapter 32 Comorbidities of migraine: Sleep disorders
- Abstract
- Introduction
- Mechanistic Considerations
- Summary
- References
- Chapter 33 The evolving concept of multimorbidity and migraine
- Abstract
- Introduction
- Cerebrovascular Diseases and Migraine
- Metabolic and Endocrine Disorders and Migraine
- Epilepsy and Migraine
- Psychiatric Disorders and Migraine
- Chronic Pain Syndromes and Migraine
- Sleep Disorders and Migraine
- Gastrointestinal Disorders and Migraine
- Immunological Disorders and Migraine
- Conclusions
- References
- Further reading
- Section VII: Future directions
- Chapter 34 Healthcare disparities encountered by patients with headache disorders and potential mitigation strategies
- Abstract
- Introduction
- The Societal Burden of Headache Disorders
- Disparities in Emergency Room Management
- Disparities in Outpatient/Subspecialty Clinic
- Socioeconomic Status/Insurance Status
- Geography
- Why Do These Disparities Exist?
- Lack of Representation in Research
- Potential Solutions to Address Headache Disparities
- Conclusion
- References
- Further reading
- Chapter 35 Emerging and future directions of migraine research and treatment
- Abstract
- Introduction
- Headache Diagnosis and Classification
- Biomarkers
- Potential Future Treatment Targets
- Conclusions
- References
- Index
- No. of pages: 632
- Language: English
- Edition: 1
- Volume: 199
- Published: February 1, 2024
- Imprint: Elsevier
- Hardback ISBN: 9780128233573
- eBook ISBN: 9780128234815
JS
Jerry W. Swanson
MM